Journal Logo

Publication Only: Myeloma and other monoclonal gammopathies – Clinical

PB2123 FEASIBILITY, TOLERABILITY AND EFFICACY OF CARFILZOMIB, LENALIDOMIDE AND DESAMETHASONE(KRD) IN RELAPSED REFRACTORY MYELOMA PATIENTS: A REAL-LIFE SURVEY OF THE SICILIAN MYELOMA NETWORK

Conticello, C.1; Martino, E.1,2; Calafiore, V.1; Sapienza, G.1,2; Del Fabro, V.1; Parisi, M.1; Garibaldi, B.1; Leotta, S.1; Markovic, U.1,2; Leotta, V.1,3; Cotzia, E.4; Innao, V.5,6; Maugeri, C.7; Poidomani, M.8; Mannina, D.9; Neri, S.9; Consoli, U.10; Merenda, A.11; Musso, M.12; Scalone, R.12; Cangialosi, C.13; Carlisi, M.14; Longo, G.15; Mineo, G.15; Romano, A.2; Di Raimondo, F.1,2

Author Information
doi: 10.1097/01.HS9.0000566976.32025.83
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.